Sign in
CompletedNo phase

Effectiveness and Safety of Pharmacopuncture Therapy for Patients with Lumbar Spinal Stenosis

Key facts

Who runs it
Jaseng Medical Foundation
Where
South Korea7 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
98 people enrolled
Started
13 Apr 2022
Ended
28 Oct 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • pharmacopuncture
  • conservative treatments (including physiotherapy)
Record updated
9 January 2025

Who can take part

Age
19 years to 69 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (17)Hide the full registry criteria

Who can take part

  • Diagnosed with lumbar spinal stenosis based on radiology including computed tomography or magnetic resonance imaging
  • Clear neurogenic claudication symptoms existed (symptoms aggravated with walking, and alleviated upon resting in lumbar flexion position)
  • reported radiating leg pain or low back pain (LBP) with intensity of NRS ≥5
  • Between the age of 19 and 69 years old
  • Participants who agreed to participate the study and voluntarily signed the informed consent form

Who cannot take part

  • Patients who administrate those prescribed medicine that may interfere with interpretation of the result (e.g. corticosteroids, immunosuppressants, physchotropic drugs)
  • Patients who were treated with one of the following intervention within the past week; medicine that may potentially influence pain such as NSAIDs (nonsteroidal antiinflammatory drugs), pharmacopuncture, or physical therapies
  • Previous participation in other clinical studies within 1 month of current study enrollment, or plans to participate in other clinical studies during participation (including follow-up period) of the current study after study enrollment
  • Patients with other systemic diseases that may interfere with treatment effect or outcome interpretation
  • Patients for whom pharmacopuncture treatment may be inappropriate or unsafe (e.g. hemorrhagic diseases, blood clotting disorders, history of anti-coagulation medicine intake, serious diabetes with risk of infection)
  • Patients with medical history of spinal surgery within the past 3 months
  • Patients with vascular claudication
  • Patients with pathologies of non-spinal origin that may cause LBP or radiating leg pain (e.g. spinal tumor, fracture)
  • Patients with soft tissue pathologies that may cause LBP or radiating leg pain (e.g. tumor, fibromyalgia, rheumatoid arthritis, gout)
  • Pregnant patients or patients planning pregnancy
  • Patients unable to fill out study participation consent form
  • Patients deemed unsuitable for study participation as assessed by the researchers

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is 1:1 pragmatic randomized controlled trials in a parallel-grouped, multi-centered design that investigated pharmacopuncture therapy for patients with lumbar spinal stenosis, compared to the conservative treatments including physiotherapy and pharmacological treatments.

The 2 groups in the trial

  • pharmacopuncture groupTreatment being tested

    The physicians will choose the type and volume of pharmacopuncture according to participants' conditions.

    Treatment: pharmacopuncture

  • conservative treatment groupExisting treatment, for comparison

    The physicians will choose the type and time of physical therapy and if needed, pharmacological treatment according to participants' conditions.

    Treatment: conservative treatments (including physiotherapy)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effectiveness and Safety of Pharmacopuncture Therapy for Patients with Lumbar Spinal Stenosis : Multicentered, Pragmatic Randomized Controlled, Parallel Grouped Study
Publications
Record updated
9 January 2025